Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Phase 2 Study of Chlorophyllin for the Management of Brain Radionecrosis in Patients With Diffuse Glioma

NCT06016452 is registered in ClinicalTrials.gov with Tata Memorial Centre as lead sponsor.

NCT NCT06016452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06016452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Phase 2 Study of Chlorophyllin for the Management of Brain Radionecrosis in Patients With Diffuse Glioma
Lead sponsor
Tata Memorial Centre
Phase
Phase 2
Overall status
Recruiting
Start date
November 13, 2023
Completion date
November 30, 2025
Enrollment
118 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse glioma, glioblastoma multiforme, high grade glioma, radionecrosis of brain